Design of the long-term observational cohort study with recombinant human growth hormone in Korean children: LG Growth Study

키워드

참고문헌 (36)

1. Romero CJ, "Pediatric endocrinology: a practical clinical guide", pp.3~28 (2013), Humana Press
2. Brown P, "Iatrogenic Creutzfeldt-Jakob disease, final assessment", Emerg Infect Dis, 18, pp.901~907 (2012)[DOI]
3. Navarro R, "Translating clinical guidelines into practice: the effective and appropriate use of human growth hormone", Am J Manag Care, 19(15 Suppl), pp.s281~s289 (2013)
4. Franklin SL, "Growth hormone: the expansion of available products and indications", Pediatr Clin North Am, 58, pp.1141~1165 (2011)[DOI]
5. Kemp SF, "Emerging options in growth hormone therapy: an update", Drug Des Devel Ther, 5, pp.411~419 (2011)
6. Allen DB, "GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults", Eur J Endocrinol, 174, pp.1~9 (2016)
7. Romer T, "Seven years of safety and efficacy of the recombinant human growth hormone Omnitrope in the treatment of growth hormone deficient children: results of a phase III study", Horm Res, 72, pp.359~369 (2009)
8. Deodati A, "Impact of growth hormone therapy on adult height of children with idiopathic short stature: systematic review", BMJ, 342, pp.c7157~ (2011)[DOI]
9. Stephure DK, "Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian randomized controlled trial", J Clin Endocrinol Metab, 90, pp.3360~3366 (2005)[DOI]
10. Kim SJ, "Development and characterization of sodium hyaluronate microparticle-based sustained release formulation of recombinant human growth hormone prepared by Spray-Drying", J Pharm Sci, 105, pp.613~622 (2016)[DOI]
11. Peter F, "Three-year efficacy and safety of LB03002, a once-weekly sustained-release growth hormone (GH) preparation, in prepubertal children with GH deficiency (GHD)", J Clin Endocrinol Metab, 97, pp.400~407 (2012)[DOI]
12. Hwang JS, "Efficacy and safety of LB03002, a once-weekly sustained-release human GH for 12-month treatment in Korean children with GH deficiency", Eur J Endocrinol, 169, pp.179~185 (2013)[DOI]
13. Khadilkar V, "24-month use of once-weekly GH, LB03002, in prepubertal children with GH deficiency", J Clin Endocrinol Metab, 99, pp.126~132 (2014)[DOI]
14. 이기형, "부당 경량아(Small for Gestational Age)로 태어난 사춘기 이전의 저신장 소아에서 6개월간 인성장호르몬(EutropinTM Inj.) 치료의 유효성과 안전성에 대한 단일군 대상, 제3상 임상시험 연구", Annals of Pediatric Endocrinology & Metabolism, 16(3), pp.157~164 (2011), 대한소아내분비학회
15. Kim DH, "Clinical effects of eutropin (recombinant human growth hormone) in patients with turner syndrome", J Korean Soc Pediatr Endocrinol, 3, pp.172~183 (1998)
16. 김호성, "Efficacy of Short-Term Growth Hormone Treatment in Prepubertal Children with Idiopathic Short Stature", Yonsei Medical Journal, 55(1), pp.53~60 (2014), 연세대학교의과대학
17. Korea Centers for Disease Control and Prevention, Division of Chronic Disease Surveillance, "2007 Korean children and adolescents growth standard (commentary for the development of 2007 growth chart)", Korea Centers for Disease Control and Prevention, Division of Chronic Disease Surveillance, ~ (2007)
18. Hyun SE, "Reference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Korean children and adolescents", Clin Biochem, 45, pp.16~21 (2012)[DOI]
19. Bell J, "Long-term safety of recombinant human growth hormone in children", J Clin Endocrinol Metab, 95, pp.167~177 (2010)[DOI]
20. Kim JH, "Long-term safety and effectiveness of daily and weekly GH treatment in pediatric patients", 54th Annual Conference of the European Society for Paediatric Endocrinology (2015), The European Society for Paediatric Endocrinology
21. Chung S, "Long-term safety and effectiveness of daily and weekly growth hormone treatment in pediatric GHD patients (4-years' results)", 55th Annual Conference of the European Society for Paediatric Endocrinology (2016), The European Society for Paediatric Endocrinology
22. Chung S, "Long-term safety and effectiveness of growth hormone treatment in pediatric patients with growth hormone deficiency: interim results of LG growth study", 55th Annual conference of the European Society for Paediatric Endocrinology (2016), The European Society for Paediatric Endocrinology
23. 임정섭, "New Korean reference for birth weight by gestational age and sex: data from the Korean Statistical Information Service (2008–2012)", Annals of Pediatric Endocrinology & Metabolism, 19(3), pp.146~153 (2014), 대한소아내분비학회
24. "The periodic health examination. Canadian Task Force on the Periodic Health Examination", Can Med Assoc J, 121, pp.1193~1254 (1979)
25. Schulz KF, "CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials", Ann Intern Med, 152, pp.726~732 (2010)[DOI]
26. Blankenstein O, "Real-life GH dosing patterns in children with GHD, TS or born SGA: a report from the <TEX>$NordiNet^{(R)}$<", TEX> International Outcome Study, 2017, pp.177, 145~155
27. Hoybye C, "The <TEX>$NordiNet^{(R)}$<", TEX> International Outcome Study and <TEX>$NovoNet^{(R)}$<, TEX>: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (<TEX>$Norditropin^{(R)}$<, pp.TEX>), Clin Epidemiol[DOI]
28. Swerdlow AJ, "Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone", Horm Res Paediatr, 84, pp.172~183 (2015)[DOI]
29. Pfaffle R, "Design of, and first data from, PATRO Children, a multicentre, noninterventional study of the long-term efficacy and safety of <TEX>$Omnitrope(^{(R)})$<", TEX> in children requiring growth hormone treatment, 2013, pp.4, 3~11
30. [URL]
31. [URL]
32. [URL]
33. Lanes R, "Long-term outcome of growth hormone therapy in children and adolescents", Treat Endocrinol, 3, pp.53~66 (2004)[DOI]
34. Desrosiers P, "Patient outcomes in the GHMonitor: the effect of delivery device on compliance and growth", Pediatr Endocrinol Rev, 2(Suppl 3), pp.327~331 (2005)
35. Kapoor RR, "Monitoring of concordance in growth hormone therapy", Arch Dis Child, 93, pp.147~148 (2008)[DOI]
36. Cutfield WS, "Non-compliance with growth hormone treatment in children is common and impairs linear growth", PLoS One, 6, pp.e16223~ (2011)[DOI]

관련 논문AI추천